Novo Holdings Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity
Novo Holdings is > 10% Shareholder of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of KALV, which is worth approximately $0. The most recent transaction as insider was on Oct 12, 2017, when has been sold 1,726,481 shares (Common Stock) at a price of $9.26 per share, resulting in proceeds of $15,987,214. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Novo Holdings Transaction History
Also insider at
NH
Novo Holdings
> 10% Shareholder
Hellerup, G7